Immunobiology and immunopharmacology of organ allograft rejection

Immunobiology and immunopharmacology of organ allograft rejection
复制标题

器官同种异体移植排斥反应的免疫生物学和免疫药理学

DOI:
--
复制
发表时间:
1995
影响因子:
9.1
通讯作者:
T. Strom
T. Strom
中科院分区:
医学2区
文献类型:
--
作者:
M. Suthanthiran;T. Strom

文献摘要

参考文献

被引文献

相似文献

关于组织不相容同种异体移植物排斥反应的免疫生物学机制已经有了很多的研究。在我们对造成容忍的机制的理解方面也取得了相当大的进展。随着对移植物破坏性同种异体免疫过程和免疫抑制剂作用机制的新认识,移植后一年的实体器官移植物存活率超过80%。耐受机制的原理尚未成功应用于临床。本文从抗同种异体移植药物的调控角度,综述了临床上常用的免疫抑制药物的分子和细胞作用机制。
Much has been learned regarding immunobiological mechanisms responsible for the rejection of histoincompatible allografts. There has also been considerable progress in our understanding of mechanisms responsible for tolerance. The new knowledge gained regarding graft destructive alloimmunity process and the mechanisms of action of immunosuppressants have resulted in solid organ graft survival rates that are in excess of 80% at one year posttransplantation. The principles of tolerance mechanisms are yet to be successfully applied in the clinic. In this review, molecular and cellular mechanisms of action of clinically useful immunosuppressive drugs are reviewed from the perspective of regulation of the anti-allograft repertory.
DOI: --
发表时间: 1991-05
影响因子: 7.8
作者:
M. Miceli;J. Parnes
通讯作者: M. Miceli;J. Parnes
Interleukin-2 受体调节磷脂酰肌醇 3-激酶的激活。
DOI: --
发表时间: 1991
期刊: The Journal of biological chemistry
影响因子: --
作者:
Remillard,B;Petrillo,R;Maslinski,W;Tsudo,M;Strom,TB;Cantley,L;Varticovski,L
通讯作者: Varticovski,L
DOI: 10.1126/science.3131876
发表时间: 1988-05-27
期刊: SCIENCE
影响因子: 56.9
作者:
SMITH, KA
通讯作者: SMITH, KA
DOI: --
发表时间: 1994
期刊: Transplantation
影响因子: 6.2
作者:
Khanna,A;Li,B;Stenzel,KH;Suthanthiran,M
通讯作者: Suthanthiran,M
白介素 2 (IL-2) 诱导酪氨酸激酶依赖性活性 raf-1 从 IL-2 受体易位至胞质溶胶中。
DOI: --
发表时间: 1992
期刊: The Journal of biological chemistry
影响因子: --
作者:
Maslinski,W;Remillard,B;Tsudo,M;Strom,TB
通讯作者: Strom,TB